You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Pharmaceutical drugs supplied by: Kesin Pharma Corporation


✉ Email this page to a colleague

« Back to Dashboard


Kesin Pharma Corporation

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Kanchan Hlthcare DEXAMETHASONE dexamethasone ELIXIR;ORAL 084754 ANDA Kesin Pharma Corporation 81033-010-24 20 CUP, UNIT-DOSE in 1 CARTON (81033-010-24) / 5 mL in 1 CUP, UNIT-DOSE (81033-010-05) 1976-09-21
Bionpharma LEVETIRACETAM levetiracetam SOLUTION;ORAL 079120 ANDA Kesin Pharma Corporation 81033-013-50 50 CUP, UNIT-DOSE in 1 CARTON (81033-013-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-013-05) 2024-07-18
Mlv NYSTATIN nystatin SUSPENSION;ORAL 062832 ANDA Kesin Pharma Corporation 81033-015-01 100 CUP, UNIT-DOSE in 1 CASE (81033-015-01) / 5 mL in 1 CUP, UNIT-DOSE (81033-015-05) 2020-08-14
Mlv NYSTATIN nystatin SUSPENSION;ORAL 062832 ANDA Kesin Pharma Corporation 81033-015-54 50 CUP, UNIT-DOSE in 1 CARTON (81033-015-54) / 5 mL in 1 CUP, UNIT-DOSE (81033-015-05) 2020-08-14
Strides Pharma PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride SYRUP;ORAL 040891 ANDA Kesin Pharma Corporation 81033-016-50 50 CUP, UNIT-DOSE in 1 CARTON (81033-016-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-016-05) 2024-12-31
Padagis Us IBUPROFEN ibuprofen SUSPENSION;ORAL 076925 ANDA Kesin Pharma Corporation 81033-018-50 100 CUP, UNIT-DOSE in 1 CASE (81033-018-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-018-05) 2025-01-01
Padagis Us IBUPROFEN ibuprofen SUSPENSION;ORAL 076925 ANDA Kesin Pharma Corporation 81033-018-52 100 CUP, UNIT-DOSE in 1 CASE (81033-018-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-018-10) 2025-01-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.